#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	3534	16S	1529	1529	99.93	16S.l15.c17.ctg.1	2425	430.5	0	.	n	.	0	C1450T	SNP	1450	1450	C	1891	1891	T	517	T,C	325,120	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	3534	16S	1529	1529	99.93	16S.l15.c17.ctg.1	2425	430.5	1	SNP	n	C1184T	0	.	.	1184	1184	C	1625	1625	C	543	C	461	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	3534	16S	1529	1529	99.93	16S.l15.c17.ctg.1	2425	430.5	0	HET	.	.	.	C451T,G	.	451	451	C	892	892	C	492	C,T,G	219,201,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	3534	16S	1529	1529	99.93	16S.l15.c17.ctg.1	2425	430.5	0	HET	.	.	.	C207T	.	207	207	C	648	648	C	507	C,T	218,207	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	5842	23S	2890	2890	99.9	23S.l6.c4.ctg.1	4018	435.5	0	.	n	.	0	T695C	SNP	695	695	T	1289	1289	C	461	C,G	383,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	5842	23S	2890	2890	99.9	23S.l6.c4.ctg.1	4018	435.5	0	.	n	.	0	T1971C	SNP	1971	1971	T	2565	2565	C	537	C,T	458,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	5842	23S	2890	2890	99.9	23S.l6.c4.ctg.1	4018	435.5	1	SNP	n	C2597T	1	C2597T	SNP	2597	2597	C	3191	3191	T	475	T,G	401,2	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	5842	23S	2890	2890	99.9	23S.l6.c4.ctg.1	4018	435.5	1	SNP	n	A2045G	0	.	.	2045	2045	A	2639	2639	A	549	A	468	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	27	558	folP	855	855	100.0	folP.l15.c4.ctg.1	1998	83.7	1	SNP	p	R229S	1	.	.	685	687	AGC	1250	1252	AGC	132;133;134	A;G;C	113;115;117	folP.WHO_Y_01480c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	1356	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3767	108.0	1	SNP	p	S91F	1	.	.	271	273	TTC	776	778	TTC	127;127;127	T;T;C	110;111;108	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	1356	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3767	108.0	1	SNP	p	D95G	1	.	.	283	285	GGC	788	790	GGC	125;124;124	G;G;C	110;108;110	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	1356	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3767	108.0	1	SNP	p	G95N	0	.	.	283	285	GGC	788	790	GGC	125;124;124	G;G;C	110;108;110	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	27	538	mtrR	633	633	100.0	mtrR.l6.c4.ctg.1	1698	94.9	1	SNP	p	G45D	0	.	.	133	135	GGC	637	639	GGC	152;150;150	G;G;C	132;129;129	mtrR.WHO_G_01393:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	348	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	1374	76.0	0	.	n	.	0	A197.	DEL	197	197	A	775	775	A	136	A	118	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1342	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3322	121.1	1	SNP	p	D86N	0	.	.	256	258	GAC	770	772	GAC	151;149;149	G;A;C	131;128;131	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1342	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3322	121.1	1	SNP	p	R87W	0	.	.	259	261	CGT	773	775	CGT	150;150;150	C;G;T,A	132;131;129,1	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1342	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3322	121.1	1	SNP	p	S87R	1	.	.	259	261	CGT	773	775	CGT	150;150;150	C;G;T,A	132;131;129,1	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1342	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3322	121.1	1	SNP	p	R87I	0	.	.	259	261	CGT	773	775	CGT	150;150;150	C;G;T,A	132;131;129,1	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1342	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3322	121.1	1	SNP	p	S88P	0	.	.	262	264	TCC	776	778	TCC	150;150;149	T;C;C	127;127;130	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	1124	parE	1986	1986	100.0	parE.l6.c17.ctg.1	2982	112.6	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1720	1722	GGC	149;150;151	G;G;C	124;124;129	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	808	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2831	85.6	1	SNP	p	A311V	0	.	.	931	933	GCC	1458	1460	GCC	123;123;122	G;C;C,A	103;103;100,1	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	808	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2831	85.6	1	SNP	p	I312M	1	.	.	934	936	ATG	1461	1463	ATG	123;123;123	A,G;T;G	106,1;105;101	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	808	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2831	85.6	1	SNP	p	T316P	0	.	.	946	948	ACC	1473	1475	ACC	122;122;120	A;C;C	108;105;107	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	808	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2831	85.6	1	SNP	p	V316T	1	.	.	946	948	ACC	1473	1475	ACC	122;122;120	A;C;C	108;105;107	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	808	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2831	85.6	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1974	1976	ACC	112;112;112	A;C;C,G	95;93;93,1	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	808	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2831	85.6	1	SNP	p	A501P	0	.	.	1501	1503	GCG	2028	2030	GCG	126;125;125	G,T;C;G	99,1;97;99	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	808	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2831	85.6	1	SNP	p	A501V	0	.	.	1501	1503	GCG	2028	2030	GCG	126;125;125	G,T;C;G	99,1;97;99	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	808	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2831	85.6	1	SNP	p	G542S	0	.	.	1624	1626	GGT	2151	2153	GGT	116;116;116	G;G;T	103;104;104	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	808	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2831	85.6	1	SNP	p	G545S	1	.	.	1633	1635	AGC	2160	2162	AGC	114;112;113	A;G;C	101;98;99	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	808	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2831	85.6	1	SNP	p	P551S	0	.	.	1651	1653	CCG	2178	2180	CCG	116;117;119	C,A,T;C;G,A	95,1,1;103;103,1	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	1358	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3489	116.4	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1853	1855	CCG	139;141;141	C;C;G	108;116;112	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	782	porA	1146	1146	99.91	porA.l6.c4.ctg.1	2190	106.8	0	.	p	.	0	M83fs	FSHIFT	247	247	A	762	762	C	135	C	117	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	86	porB1a	984	296	91.0	porB1a.l15.c4.ctg.2	412	7.2	0	.	p	.	0	H217N	NONSYN	649	651	CAT	141	143	AAT	8;8;8	A;A;T	8;7;8	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	86	porB1a	984	296	91.0	porB1a.l15.c4.ctg.2	412	7.2	0	.	p	.	0	D218N	NONSYN	652	654	GAT	144	146	AAT	8;8;8	A;A;T	7;8;7	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	86	porB1a	984	296	91.0	porB1a.l15.c4.ctg.2	412	7.2	0	.	p	.	0	V226A	NONSYN	676	678	GTA	168	170	GCA	8;8;8	G;C;A	8;8;8	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	86	porB1a	984	296	91.0	porB1a.l15.c4.ctg.2	412	7.2	0	.	p	.	0	.	MULTIPLE	700	702	ACT	191	193	GTA	8;8;8	G;T;A	8;8;8	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	86	porB1a	984	296	91.0	porB1a.l15.c4.ctg.2	412	7.2	0	.	p	.	0	N237fs	FSHIFT	709	709	A	200	200	A	8	A	8	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	666	porB1b	1038	1038	99.81	porB1b.l15.c4.ctg.1	1877	104.5	0	.	p	.	0	G210R	NONSYN	628	630	GGA	1142	1144	AGA	153;153;152	A,G;G;A	132,1;132;129	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	666	porB1b	1038	1038	99.81	porB1b.l15.c4.ctg.1	1877	104.5	0	.	p	.	0	S217G	NONSYN	649	651	AGT	1163	1165	GGT	151;151;150	G,A;G;T	130,1;130;128	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	666	porB1b	1038	1038	99.81	porB1b.l15.c4.ctg.1	1877	104.5	1	SNP	p	G120K	1	.	.	358	360	AAG	872	874	AAG	143;143;143	A,T;A;G	124,1;125;127	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	666	porB1b	1038	1038	99.81	porB1b.l15.c4.ctg.1	1877	104.5	1	SNP	p	N121D	0	.	.	361	363	AAC	875	877	AAC	142;141;141	A;A;C	124;125;121	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	666	porB1b	1038	1038	99.81	porB1b.l15.c4.ctg.1	1877	104.5	1	SNP	p	A121N	1	.	.	361	363	AAC	875	877	AAC	142;141;141	A;A;C	124;125;121	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	2328	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	5307	131.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	294	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1332	65.9	1	SNP	p	V57M	1	.	.	169	171	ATG	627	629	ATG	108;108;108	A;T,C;G	94;92,1;94	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
